Opinion

Video

Reducing Recurrence in NMIBC and Novel Treatment Approaches on the Horizon

Experts consider other pipeline treatments for non-muscle invasive bladder cancer (NMIBC), including new injectable options being explored.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Related Videos
      1 expert in this video
      Clinical Outcomes of Ultra-Low PSA Responses in Patients With mHSPC Receiving Darolutamide Plus ADT
      2 experts are featured in this series.
      Treatment or Lack of Treatment of Small Renal Masses
      1 expert is featured in this series.
      The current treatment landscape of mHSPC
      2 experts are featured in this series.
      Strengths and Weaknesses of Imaging Modalities in ccRCC
      1 expert in this video
      BPH: Strategies for Guiding Patients From Medication to Intervention
      1 expert is featured in this series.
      Representation of Black men with mHSPC in clinical trials
      1 expert in this video
      Post Hoc Analysis of ARANOTE; Ultra-Low PSA Responses
      4 experts in this video
      Non–Muscle Invasive-Bladder Cancer Overview
      NMIBC Maintenance Therapy: Timing, Dosing, and Follow-Up
      NMIBC Maintenance Therapy: Timing, Dosing, and Follow-Up
      1 expert is featured in this series.
      BRCA Mutations in mHSPC: Impact on Therapy Selection
      Related Content
      © 2025 MJH Life Sciences

      All rights reserved.